Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Kulkarni Samarth
Relationship:  
City:   Cambridge
State:   MA
   
Insider Summary:
  
   
Companies Owned :   1    
Direct Shares   208,122    

Indirect Shares

   200,000      
Direct Value   $11,644,426    

Indirect Value

   $11,190,000      
Total Shares   408,122      
Total Value   $22,834,426      


Crispr Therapeutics Ag $11,644,426 Crispr Therapeutics Ag $11,644,426
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    3    

     Stock price went up :
    0   
    0    
     Stock price went down :
    0   
    3    
   
     Gain/Loss Ratio :
   0.0   
   -3.0   
     Percentage Gain/Loss :
     0.0%
 -67.6%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Crispr Therapeutics Ag CRSP 2024-04-15 208,122 2024-04-15 200,000    Premium*  
* Premium Members only  

Records found :    113         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 3 of 5
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
CRSP Crispr Therapeutics Ag Chief Executive Officer   •       •      –    2021-09-01 4 D $124.83 $98,241 D/D (787) 186,932 0 -
CRSP Crispr Therapeutics Ag Chief Executive Officer   •       •      –    2021-12-01 4 D $75.10 $58,503 D/D (779) 219,153 0 -
CRSP Crispr Therapeutics Ag Chief Executive Officer   •       •      –    2021-12-06 4 D $69.17 $2,615,871 D/D (37,818) 261,335 0 -
CRSP Crispr Therapeutics Ag Chief Executive Officer   •       •      –    2022-03-11 4 D $62.56 $343,267 D/D (5,487) 285,432 0 -
CRSP Crispr Therapeutics Ag Chief Executive Officer   •       •      –    2022-03-14 4 D $61.08 $253,665 D/D (4,153) 290,279 0 -
CRSP Crispr Therapeutics Ag Chief Executive Officer   •       •      –    2022-12-05 4 D $52.26 $1,013,896 D/D (19,401) 310,878 0 -
CRSP Crispr Therapeutics Ag Chief Executive Officer   •       •      –    2023-02-21 4 D $48.26 $307,561 D/D (6,373) 375,988 0 -
CRSP Crispr Therapeutics Ag Chief Executive Officer   •       •      –    2023-03-13 4 D $43.22 $408,170 D/D (9,444) 387,377 0 -
CRSP Crispr Therapeutics Ag Chief Business OfficerOfficer   •       –      –    2016-10-18 3 IO $0.00 $0 D/D 0 134,047 -
CRSP Crispr Therapeutics Ag Chief Business Officer   •       –      –    2017-04-19 4 OE $1.81 $13,137 D/D 7,258 141,305 0 -
CRSP Crispr Therapeutics Ag Chief Business Officer   •       –      –    2017-04-20 4 OE $1.81 $5,068 D/D 2,800 136,847 0 -
CRSP Crispr Therapeutics Ag Chief Business Officer   •       –      –    2017-04-21 4 OE $1.81 $5,430 D/D 3,000 137,047 0 -
CRSP Crispr Therapeutics Ag Chief Business Officer   •       –      –    2017-04-24 4 OE $1.81 $6,335 D/D 3,500 137,547 0 -
CRSP Crispr Therapeutics Ag Chief Business Officer   •       –      –    2017-04-25 4 OE $1.81 $9,258 D/D 5,115 139,162 0 -
CRSP Crispr Therapeutics Ag Chief Business Officer   •       –      –    2017-04-26 4 OE $1.81 $5,928 D/D 3,275 137,322 0 -
CRSP Crispr Therapeutics Ag Chief Business Officer   •       –      –    2017-04-27 4 OE $1.81 $3,993 D/D 2,206 136,253 0 -
CRSP Crispr Therapeutics Ag Chief Executive Officer   •       –      –    2017-12-21 4 OE $1.81 $27,150 D/D 15,000 148,560 0 -
CRSP Crispr Therapeutics Ag Chief Executive Officer   •       •      –    2018-06-01 4 OE $1.81 $27,150 D/D 15,000 163,560 0 -
CRSP Crispr Therapeutics Ag Chief Executive Officer   •       •      –    2018-12-07 4 OE $1.81 $38,915 D/D 21,500 167,290 0 -
CRSP Crispr Therapeutics Ag Chief Executive Officer   •       •      –    2019-04-29 4 OE $1.81 $36,200 D/D 20,000 186,542 0 -
CRSP Crispr Therapeutics Ag Chief Executive Officer   •       •      –    2019-06-17 4 OE $1.81 $36,200 D/D 20,000 185,801 0 -
CRSP Crispr Therapeutics Ag Chief Executive Officer   •       •      –    2019-12-16 4 OE $1.81 $14,480 D/D 8,000 172,320 0 -
CRSP Crispr Therapeutics Ag Chief Executive Officer   •       •      –    2020-05-19 4 OE $1.81 $7,796 D/D 4,307 175,833 0 -
CRSP Crispr Therapeutics Ag Chief Executive Officer   •       •      –    2020-05-20 4 OE $1.81 $19,354 D/D 10,693 182,219 0 -
CRSP Crispr Therapeutics Ag Chief Executive Officer   •       •      –    2020-06-01 4 OE $1.81 $31,268 D/D 17,275 188,801 0 -
  113  Records found
  1   2   3  4   5      
  Page 3 of 5  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us